menu
    • menu

    Company profile for Delta-Fly Pharma

    NEW Drugs in Dev: 5
    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    AbbVie Contract Manufacturing partners globally to develop, scale, and manufacture pharmaceutical products successfully.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Delta-Fly Pharma is celebrating its 10th year since it was established on December 6, 2010. With our module drug development concept, we develop new anticancer drugs that have improved balance of safety and efficacy by using existing drugs and compounds with anticancer properties as components in our products. The growing number of cancer patients accompanying the aging population is a major issue as many of the existing an...
    Delta-Fly Pharma is celebrating its 10th year since it was established on December 6, 2010. With our module drug development concept, we develop new anticancer drugs that have improved balance of safety and efficacy by using existing drugs and compounds with anticancer properties as components in our products. The growing number of cancer patients accompanying the aging population is a major issue as many of the existing anticancer treatments are very expensive and place a significant economic burden on patients and governments that pay for treatments. In addition, many anticancer treatments are known to have debilitating side effects.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Delta-Fly Pharmajapan Flag
    Country
    Country
    Japan
    Address
    Address
    --
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.delta-flypharma.co.jp/en/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/delta-fly-pharma%E6%A0%AA%E5%BC%8F%E4%BC%9A%E7%A4%BE/about/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Delta-Fly Updates On DFP-10917 & Venetoclax Combination Study
    Delta-Fly Updates On DFP-10917 & Venetoclax Combination Study

    28 Feb 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250228414852/en

    BUSINESSWIRE
    28 Feb 2025
    Share Share
    Delta-Fly Pharma Update for Development Status of DFP-17729
    Delta-Fly Pharma Update for Development Status of DFP-17729

    04 Dec 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241204497142/en

    BUSINESSWIRE
    04 Dec 2024
    Share Share
    Delta-Fly Progress Update of the Ph 3 Clinical Trial of DFP-14323
    Delta-Fly Progress Update of the Ph 3 Clinical Trial of DFP-14323

    26 Nov 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241126520530/en

    BUSINESSWIRE
    26 Nov 2024
    Share Share
    Delta-Fly Pharma Update for Expanded Phase I Study of DFP-14927
    Delta-Fly Pharma Update for Expanded Phase I Study of DFP-14927

    05 Nov 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241105884234/en

    BUSINESSWIRE
    05 Nov 2024
    Share Share
    Delta-Fly Pharma Begins Promising AML Phase I/II Study
    Delta-Fly Pharma Begins Promising AML Phase I/II Study

    28 Oct 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241028538375/en

    BUSINESSWIRE
    28 Oct 2024
    Share Share
    Delta-Fly Initiates DFP-10917 Phase I/II Combo-study In AML
    Delta-Fly Initiates DFP-10917 Phase I/II Combo-study In AML

    10 Sep 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240910878901/en

    BUSINESSWIRE
    10 Sep 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search